Literature DB >> 12207537

Electronic structure and reactivity of low-spin Fe(III)-hydroperoxo complexes: comparison to activated bleomycin.

Nicolai Lehnert1, Frank Neese, Raymond Y N Ho, Lawrence Que, Edward I Solomon.   

Abstract

The spectroscopic properties, electronic structure, and reactivity of the low-spin Fe(III)-hydroperoxo complex [Fe(N4Py)(OOH)](2+) (1, N4Py = N,N-bis(2-pyridylmethyl)-N-bis(2-pyridyl)methylamine) are investigated in comparison to those of activated bleomycin (ABLM). Complex 1 is characterized by Raman features at 632 (Fe-O stretch) and 790 cm(-1) (O-O stretch), corresponding to a strong Fe-O bond (force constant 3.62 mdyn/A) and a weak O-O bond (3.05 mdyn/A). The UV-vis spectrum of 1 shows a broad absorption band around 550 nm that is assigned to a charge-transfer transition from the hydroperoxo to a t(2g) d orbital of Fe(III) using resonance Raman and MCD spectroscopies and density functional (DFT) calculations. Compared to low-spin [Fe(TPA)(OH(x))(OO(t)Bu)](x+)(TPA = tris(2-pyridylmethyl)amine, x = 1 or 2), an overall similar Fe-OOR bonding results for low-spin Fe(III)-alkylperoxo and -hydroperoxo species. Correspondingly, both systems show similar reactivities and undergo homolytic cleavage of the O-O bond. From the DFT calculations, this reaction is more endothermic for 1 due to the reduced stabilization of the .OH radical compared to .O(t)Bu and the absence of the hydroxo ligand that helps to stabilize the resulting Fe(IV)=O species. In contrast, ABLM has a somewhat different electronic structure where no pi donor bond between the hydroperoxo ligand and iron(III) is present [Neese, F.; Zaleski, J. M.; Loeb-Zaleski, K.; Solomon, E. I. J. Am. Chem. Soc. 2000, 122, 11703]. Possible reaction pathways for ABLM are discussed in relation to known experimental results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207537     DOI: 10.1021/ja012621d

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  20 in total

Review 1.  Non-heme iron enzymes: contrasts to heme catalysis.

Authors:  Edward I Solomon; Andrea Decker; Nicolai Lehnert
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-21       Impact factor: 11.205

Review 2.  Synthetic analogues of cysteinate-ligated non-heme iron and non-corrinoid cobalt enzymes.

Authors:  Julie A Kovacs
Journal:  Chem Rev       Date:  2004-02       Impact factor: 60.622

3.  Resonance Raman detection of the hydroperoxo intermediate in the cytochrome P450 enzymatic cycle.

Authors:  Piotr J Mak; Ilia G Denisov; Doreen Victoria; Thomas M Makris; Tianjing Deng; Stephen G Sligar; James R Kincaid
Journal:  J Am Chem Soc       Date:  2007-04-27       Impact factor: 15.419

4.  Near-IR MCD of the nonheme ferrous active site in naphthalene 1,2-dioxygenase: correlation to crystallography and structural insight into the mechanism of Rieske dioxygenases.

Authors:  Takehiro Ohta; Sarmistha Chakrabarty; John D Lipscomb; Edward I Solomon
Journal:  J Am Chem Soc       Date:  2008-01-12       Impact factor: 15.419

5.  Evidence that the fosfomycin-producing epoxidase, HppE, is a non-heme-iron peroxidase.

Authors:  Chen Wang; Wei-chen Chang; Yisong Guo; Hui Huang; Spencer C Peck; Maria E Pandelia; Geng-min Lin; Hung-wen Liu; Carsten Krebs; J Martin Bollinger
Journal:  Science       Date:  2013-10-10       Impact factor: 47.728

Review 6.  Copper active sites in biology.

Authors:  Edward I Solomon; David E Heppner; Esther M Johnston; Jake W Ginsbach; Jordi Cirera; Munzarin Qayyum; Matthew T Kieber-Emmons; Christian H Kjaergaard; Ryan G Hadt; Li Tian
Journal:  Chem Rev       Date:  2014-03-03       Impact factor: 60.622

7.  Structure and reactivity of a mononuclear non-haem iron(III)-peroxo complex.

Authors:  Jaeheung Cho; Sujin Jeon; Samuel A Wilson; Lei V Liu; Eun A Kang; Joseph J Braymer; Mi Hee Lim; Britt Hedman; Keith O Hodgson; Joan Selverstone Valentine; Edward I Solomon; Wonwoo Nam
Journal:  Nature       Date:  2011-10-26       Impact factor: 49.962

8.  The metal bonding domain of the antitumor drug Fe(II)-bleomycin: a DFT investigation.

Authors:  Anna Karawajczyk; Francesco Buda
Journal:  J Biol Inorg Chem       Date:  2004-12-01       Impact factor: 3.358

9.  Peroxo and oxo intermediates in mononuclear nonheme iron enzymes and related active sites.

Authors:  Edward I Solomon; Shaun D Wong; Lei V Liu; Andrea Decker; Marina S Chow
Journal:  Curr Opin Chem Biol       Date:  2009-03-09       Impact factor: 8.822

10.  Characterization of an Fe III-OOH species and its decomposition product in a bleomycin model system.

Authors:  Michael R Bukowski; Shourong Zhu; Kevin D Koehntop; William W Brennessel; Lawrence Que
Journal:  J Biol Inorg Chem       Date:  2003-10-15       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.